Sector
PharmaceuticalsOpen
₹78.5Prev. Close
₹78.35Turnover(Lac.)
₹46.59Day's High
₹80.9Day's Low
₹7752 Week's High
₹114.552 Week's Low
₹52.8Book Value
₹0Face Value
₹10Mkt Cap (₹ Cr.)
138.73P/E
12.22EPS
6.41Divi. Yield
0
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|
Equity Capital | 0.4 | 0.4 | 0.4 |
Preference Capital | 0 | 0 | 0 |
Reserves | 12.45 | 9.24 | 6.17 |
Net Worth | 12.85 | 9.64 | 6.57 |
Minority Interest |
No Record found
No Record found
No Record found
| Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|
Gross Sales | 131.62 | 114.52 | 91.66 |
Excise Duty | 0 | 0 | 0 |
Net Sales | 131.62 | 114.52 | 91.66 |
Other Operating Income | 0 | 0 | 0 |
Other Income | 2.28 | 1.24 | 1.01 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,568.65 | 123.31 | 3,76,323.69 | 867.6 | 0.86 | 5,536.99 | 98.75 |
Divis Laboratories Ltd DIVISLAB | 4,519.8 | 76.17 | 1,19,994.45 | 531 | 0.66 | 2,259 | 507.93 |
Cipla Ltd CIPLA | 1,485.5 | 32.29 | 1,19,928.54 | 1,038.4 | 0.57 | 3,444.92 | 346.41 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,144.45 | 33.51 | 1,15,173.54 | 1,405.2 | 0.26 | 3,172.6 | 156.19 |
Dr Reddys Laboratories Ltd DRREDDY | 6,636 | 25.85 | 1,10,759.07 | 1,034.8 | 0.6 | 5,081.8 | 1,458.96 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Managing Director
Sandeep Bhardwaj
Executive Director
Bhupesh Soni
Executive Director
Ajay Singh Dassundi
Non Executive Director
Anil Malik
Independent Director
Ranjana Sureshkumar Sehgal
Independent Director
Deendayal Kumawat
Company Sec. & Compli. Officer
Sakshi Bhawsar
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Zenith Drugs Ltd
Summary
Zenith Drugs Ltd was originally incorporated on November 15, 2000 as a Private Limited Company in the name of Zenith Drugs Private Limited issued by the Registrar of Companies, in the State of Madhya Pradesh, Gwalior. Subsequently, Company was converted into Public Limited and consequently, the name of Company was changed to Zenith Drugs Limited pursuance to issuance of a Fresh Certificate of Incorporation on September 13, 2023 by the Registrar of Companies, Gwalior. Zenith are a reputable pharmaceutical manufacturing and trading unit based out from Indore. With a diverse portfolio of formulations, the Company is specialized in manufacturing affordable and high quality medicines to meet the needs of patients. The Company is mainly engaged in the business of manufacturing and Trading of Medicines. It offers a wide range of formulations in various forms such as: ORS Powder; Liquid Orals; Oinments; Liquid Externals and Capsules. The Company was established in 2000 by the visionary founders, Late Shri Ramniklal Soni, and Mr. Mukesh Jain. Initially in 2001, Company started as a modest manufacturing house for oral and external formulations. However, recognizing the importance of quality and compliance, the Company swiftly shifted to a Schedule M GMP compliant unit in 2004 where it started the production of two lines which are liquid orals and ointments. In 2007, it expanded the product line by incorporating ORS Powder manufacturing into their operations. In 2016, the Company establ
Read More
What is the Zenith Drugs Ltd share price today?
The Zenith Drugs Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is Rs.₹80.9 today.
What is the Market Cap of Zenith Drugs Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Zenith Drugs Ltd is ₹138.73 Cr. as of 22 Jul ‘24
What is the PE and PB ratio of Zenith Drugs Ltd?
The PE and PB ratios of Zenith Drugs Ltd is 12.22 and 2.16 as of 22 Jul ‘24
What is the 52 Week High and Low of Zenith Drugs Ltd?
The 52-week high/low is the highest and lowest price at which a Zenith Drugs Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Zenith Drugs Ltd is ₹52.8 and ₹114.5 as of 22 Jul ‘24
What is the CAGR of Zenith Drugs Ltd?
Zenith Drugs Ltd's CAGR for 5 Years at N/I%, 3 Years at N/I%, 1 Year at N/I%, 6 Month at -25.49%, 3 Month at 25.06% and 1 Month at 23.87%.
What is the shareholding pattern of Zenith Drugs Ltd?
The shareholding pattern of Zenith Drugs Ltd is as follows:
Promoters - 69.98 %
Institutions - 7.74 %
Public - 22.28 %
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
